Hereditary haemochromatosis: Novel genes, novel diseases and hepcidin;Hereditaire hemochromatose: Nieuwe genen, nieuwe ziekten en hepcidine

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 20, 2007, Pages 1121-1127

  Bergmans, J P H ^a   Kemna, E H J M ^a   Janssen, M C H ^a   Jacobs, E M G ^a   Stalenhoef, A F H ^a   Marx, J J M ^a   Swinkels, D W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROPORTIN 1; HEPCIDIN; HFE PROTEIN; IRON; ANTIMICROBIAL CATIONIC PEPTIDE; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PRACTICE; FERRITIN BLOOD LEVEL; GENETIC DISORDER; HEMOCHROMATOSIS; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; IRON METABOLISM; METABOLIC SYNDROME X; PREVALENCE; TISSUE INJURY; BIOSYNTHESIS; BLOOD; GENETICS; LIVER; METABOLISM; MUTATION; PHYSIOLOGY; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER; MEMBRANE PROTEINS; MUTATION;

EID: 34447095257     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Swinkels DW, Janssen MC, Bergmans J, Marx JJM. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem. 2006;52:950-68.
2. Kemna EHJM, Pickkers P, Nemeth E, Hoeven H van der, Swinkels DW. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005;106:1864-6.
3. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-3.
4. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-3.
5. Swinkels DW, Jacobs EMG. Van gen naar ziekte; HFE-mutaties bij primaire hemochromatose. Ned Tijdschr Geneeskd. 2003;147:652-6.
6. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36: 77-82.
7. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-2.
8. Camaschella C, Roetto A, Cali A, de Gobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25:14-5.
9. Njajou OT, Vaessen N, Joosse M, Berghuis B, Dongen JW van, Breuning MH, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213-4.
10. Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood. 2005;105:1337-42.
11. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531-9.
12. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
13. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med. 2004;350:2383-97.
14. Jacobs EMG, Meulendijks CF, Elving LD, Wilt GJ van der, Swinkels DW. Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis. Neth J Med. 2005;63:205-14.
15. Jacobs EMG, Vries RA de, Elving LD, Stalenhoef AFH, Swinkels DW. Diagnostiek bij 5 patiënten met mogelijk primaire hemochromatose. Ned Tijdschr Geneeskd. 2003;147:666-70.
16. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 1997;349:95-7.
17. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol. 2001;96:2448-55.
18. Swinkels DW, Marx JJM. Diagnostiek en behandeling van primaire hemochromatose. Ned Tijdschr Geneeskd. 1999;143:1404-8.
19. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→ A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-8.
20. Dijk BAC van, Kemna EHJM, Tjalsma H, Klaver SM, Wiegerinck ETG, Goossens JP, et al. A new hemojuvelin mutation - HJV-L165X: no evidence for a modifying effect on penetrance of HFE in an extended Dutch family with hereditary hemochromatosis. Blood. [ter perse].
21. US Preventive Services Task Force. Screening for hemochromatosis: recommendation statement. Ann Intern Med. 2006;145:204-8.
22. Powell LW, Dixon JL, Hewett DG. Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis. Best Pract Res Clin Haematol. 2005;18:221-34.
23. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669-73.
24. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2005;105:1803-6.
25. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103-5.
26. Kemna EHJM, Tjaisma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53:620-8.
27. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer. 2007;48:57-63.
28. Kemna EHJM, Tjaisma H, Laarakkers C, Nemeth E, Willems H, Swinkels DW. Novel urine hepcidin assay by mass spectrometry. Blood. 2005;106:3268-70.
29. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204-9.
30. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-81.
31. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, et al. Noninvasive assessment of hepatic iron stores by MRI. Lancet. 2004;363: 357-62.
32. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005; 105:855-61.
33. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, et al. Identification of an intestinal heme transporter. Cell. 2005;122:789-801.